... phase II andtranslational study of cetuximab in metastatic colorectalcarcinoma refractory to irinotecan, oxaliplatin, andfluoropyrimidines. J Clin Oncol 24, 4914–4921.3 Khambata-Ford S, Garrett ... therapy for advanced non-small cell lung can-cer with epidermal growth factor receptor mutations. BrJ Cancer 95, 998–1004.16 Sutani A, Nagai Y, Udagawa K, Uchida Y, KoyamaN, Murayama Y, Tanaka ... Inoue A, Hagiwara K, Sunaga N,Yanagitani N, Hida T et al. (2009) Combined SurvivalAnalysis of Prospective Clinical Trials of Gefitinib forNon-Small Cell Lung Cancer with EGFR Mutations.Clin...